Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04836455 · ClinicalTrials.gov registry record · NA

Impact of Vaping Prevention Advertisements

A NA study of Vaping, sponsored by UNC Lineberger Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
1,565
Enrollment target
1
Study location

NCT04836455 is a NA study of Vaping that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 1,565 participants, above the 674-participant average among 18 other Vaping trials with a reported enrollment target (132% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04836455, a NA study of Vaping, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
1,565 participants
Enrollment target
1
Study location

Study Summary

The purpose of this randomized controlled trial is to determine whether exposure to vaping prevention advertisements (ads) reduce susceptibility to vaping among adolescents. Previous studies have been informative, but they have tended to be one-time experimental studies that do not replicate the repeated exposures to ads that people have in the real world. This study addresses this issue by repeatedly exposing participants to vaping prevention ads over time. Participants will be adolescents aged 13-17 who currently vape or who are susceptible to vaping. Participants will be randomly assigned to ad stimuli. They will be assigned to one of two The Real Cost trial arms-health harms or addiction-or to a control trial arm (probability of assignment is 1/3 for all trial arms). Participants in the study will take 4 online surveys over a 3-week period, once per week (At week 0, 1, 2, and 3). All participants will view randomized ad stimuli based on their trial arm and answer surveys items at each session.

Conditions Studied

Interventions

  • BEHAVIORAL The FDA's The REal Cost vaping prevention ads - Health harms theme
  • BEHAVIORAL The FDA's The Real Cost vaping prevention ads - Addiction theme
  • BEHAVIORAL Neutral vaping ads

Study Locations (1)

North Carolina

  • University of North Carolina, Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 1,565 participants
Start Date 2021-07-03
Est. Completion 2021-11-03
Phase NA

What the Registry Record Tells You About NCT04836455

The ClinicalTrials.gov registry entry for NCT04836455 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,565 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 674-participant average among 18 other Vaping trials with a reported enrollment target (132% higher). The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vaping appearing as the primary indexed condition, and to 3 interventions - of which The FDA's The REal Cost vaping prevention ads - Health harms theme is the first listed.

NCT04836455 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04836455 about?

NCT04836455 is a clinical study titled "Impact of Vaping Prevention Advertisements". The purpose of this randomized controlled trial is to determine whether exposure to vaping prevention advertisements (ads) reduce susceptibility to vaping among adolescents. Previous studies have been informative, but they have tended to be one-time experimental studies that do not replicate the rep...

What is the current status of trial NCT04836455?

This trial is currently completed. It is a NA study. The enrollment target is 1,565 participants. The study started on 2021-07-03. Estimated completion is 2021-11-03.

What conditions does trial NCT04836455 study?

This clinical trial studies the following conditions: Vaping.

What interventions are being tested in trial NCT04836455?

The interventions under investigation include: The FDA's The REal Cost vaping prevention ads - Health harms theme (BEHAVIORAL), The FDA's The Real Cost vaping prevention ads - Addiction theme (BEHAVIORAL), Neutral vaping ads (BEHAVIORAL).

Who is sponsoring clinical trial NCT04836455?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04836455 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vaping

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.